[1] Chacko TK,Zhuang H,Nakhoda KZ,et al.Applications of fluorodeoxyglucose positron emission tomography in the diagnosis of infection.Nucl Med Commun,2003,24(6):615-624.
[2] De Winter F,Vogelaers D,Gemmel F,et al.Promising role of 18F-fluoro-D-deoxyglucose positron emission tomography in clinical infectious diseases.Eur J Clin Microbiol Infect Dis,2002,21(4):247-257.
[3] Meller J,Becker W.Nuclear medicine diagnosis of patients with fever of unknown origin (FUO).Nuklearmedizin,2001,40(3):59-70.
[4] Mamede M,SagaT,IshimoriT,etal.Differential uptake of 18F-fluorodeoxyglucose by experimental tumors xenografted into immunocompetent and immunodeficient mice and the effect of immunomodification.Neoplasia,2003,5(2):179-183.
[5] Guhlmann A,Brecht-Krauss D,Suger G,et al.Fluorine-18-FDG PET and technetium-99m antigranulocyte antibody scintigraphy in chronic osteomyelitis.J Nucl Med,1998,39(12):2145-2152.
[6] De Winter F,van de Wiele C,Vogelaers D,et al.Fluorine-18fluorodeoxyglucose-position emission tomography:a highly accurate imaging modality for the diagnosis of chronic musculoskeletal infections.J Bone Joint Surg Am,2001,83-A(5):651-660.
[7] Scher DM,Pak K,Lonner JH,et al.The predictive value of indium-111 leukocyte scans in the diagnosis of infected total hip,knee,or resection arthroplasties.J Arthroplasty,2000,15(3):295-300.
[8] Zhuang HM,Duarte PS,Pourdehand M,et al.The promising role of F-18-FDG PET in detecting infected lower limbprosthesis implants.J Nucl Med,2001,42(1):44-48.
[9] Love C,Pugliese PV,Afriyie MO,et al.Utility of F-18 FDG imaging for diagnosis the infected joint replacement.Clin Positron Imaging,2000,3(4):159.
[10] Zhuang HM,Moussavian B,Ponzo F,et al.The location,not intensity,of the tracer uptake,is a critical criterion in making a correct diagnosis of periprosthetic infection in patients with painful hip prostheses by FDG-PET.J Nucl Med,2001,45(5):129.
[11] O'Doherty M J,Barrington SF,Campbell M,et al.PET scanning and the human immunodeficiency virus-positive patient.J Nucl Med,1997,38(10):1575-1583.
[12] Hoffman JM,Waskin HA,Schifter T,et al.FDG-PET in differentiating lymphoma from nonmalignant central nervous system lesions in patients with AIDS.J Nucl Med,1993,34(4):567-575.
[13] Yamada Y,Uchida Y,Tatsumi K,et al.Fluorine-18-fluorodeoxyglucose and carbon-11-methionine evauation of lymphadenopathy in sarcoidosis.J Nuc Med,1998,39(7):1160-1166.
[14] Zhuang HM,Alavi A.18-Fluorodeoxyglucose positron emission tomographic imaging in the detection and monitoring of infection and inflammation.Semin Nucl Med,2002,32(1):47-59.
[15] Dreyer M,Borgwardt L,Reichnitzer C,et al.The role of whole body FDG-PET in pediatric patients with fever of unknown origin.Clin Nucl Med,2001,42:142.
[16] Meller J,Altenvoerde G,Munzel U,et al.Fever of unknown origin:prospective comparison of F-18-FDG imaging with a double-head coincidence camera and gallium-67 citrate SPET.Eur J Nucl Med,2000,27(11):1617-1625.
[17] Blockmans D,Knockaert D,Maes A,et al.Clinical value of F-18-fluoro-deoxyglueose positron emission tomography for patients with fever of unknown origin.Clin Infect Dis,2001,32(2):191-196.
[18] Blockmans D,Maes A,Stroobants S,et al.New arguments for a vasculitic nature of polymyalgia rheumatica using positron emission tomography.Rheumatology,1999,38(5):444-447.
[19] Maes A,Blockmans D,Stroobants S,et al.Diagnosis of systemic vasculitis using positron emission tomography.J Nucl Med,1998,39(7):1170.
[20] Lemberg DA,Issenman RM,Cawdron R,et al.Positron emission tomography in the investigation of pediatric inflammatory bowel disease.Inflamm Bowel Dis,2005,11(8):733-738.